title: Effectiveness of rituximab for chemotherapy-resistant multiple tumoral B-LPD in a haemopoietic stem cell recipient.
authors.forename: Shinsaku
authors.initials: S
authors.lastname: Imashuku
authors.forename: Mayumi
authors.initials: M
authors.lastname: Naya
authors.forename: Shinichi
authors.initials: S
authors.lastname: Tamura
authors.forename: Byongmun
authors.initials: B
authors.lastname: An
authors.forename: Tomoko
authors.initials: T
authors.lastname: Teramura
authors.forename: Mijako
authors.initials: M
authors.lastname: Kobayashi
authors.forename: Kenichi
authors.initials: K
authors.lastname: Nomura
authors.forename: Masafumi
authors.initials: M
authors.lastname: Taniwaki
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D019008:Drug Resistance, Neoplasm; D006801:Humans; D016393:Lymphoma, B-Cell / Q000188:drug therapy*; D008297:Male; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab